On behalf of the board of OneAtom 12 Limited (Company), I am pleased to present this Prospectus and to invite you to become a shareholder in the Company.
The Company was formed with the purpose to commercialise a series of membrane technologies in the growing global water treatment space. The emphasis has been to match commercially available technologies with markets and with that in mind our first plant is progressing in China. Our first membrane aims to be a world leading acid separation membrane aimed at the Industrial Treatment market in the Peoples Republic of China.
Our innovation does not end there, as our partnership with the Commonwealth Government Australian Research Council programme and Monash University is developing the next range of smart membrane technology using small amounts of graphene oxide to improve performance and begin to add selectivity to the membrane.
As the Company continues to develop its markets in China, it will continue to strategically assess new markets in the United States, Europe and Africa, and seek partners that will continue to de-risk our commercial and technical process so as to bring the best possible value to our share-holders.
The purpose of the Public Offer is to raise up to $3,000,000 (before associated costs) by the issue of up to 37,500,000 Shares at an issue price of $0.08 each. The Lead Manager of the Public Offer is Patersons Securities Limited (see Section 1.1 for further details of the Public Offer).
The proceeds of the Public Offer will be utilised to enable the Company to pay:
- costs associated with completing a manufacturing facility in China;
- further development costs in relation to its graphene enhanced membrane in association with Monash University;
- corporate costs and overheads; and
- general working capital and costs of the Offers.
This Prospectus contains detailed information about the Offers and the current and proposed operations of the Company, as well as the risks pertaining to an investment in the Company. Potential investors in the Company should carefully consider those risks (detailed in Section 9).
We look forward to welcoming you as a Shareholder.